Insecticides (India) Limited (INSECTICID) AI Stock Analysis

• Market Cap: ₹17.66B
• Dividend Yield: 0.71%
• Average Volume (3M): 1.17K
• Price to Earnings (P/E): 11.9
• Beta (1Y): 1.21
• Revenue Growth: 6.86%
• EPS Growth: 15.64%
• Country: IN
• Employees: 1,615
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Agricultural Inputs
• EPS (TTM): N/A
• Shares Outstanding: 29,097,837
• 10 Day Avg. Volume: 1,936
• 30 Day Avg. Volume: 1,171
• PEG Ratio: 0.32
• Price to Book (P/B): 1.69
• Price to Sales (P/S): 0.91
• P/FCF Ratio: 32.57
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 68 Neutral
• Price Target: ₹644.00 ▼(-9.38% Downside)

The score is supported primarily by strong financial performance (growth, improving profitability, solid balance sheet, and generally healthy cash flows). This is partially offset by weak technicals (price below key moving averages and negative MACD), while valuation is supportive with a moderate P/E and a modest dividend yield.

Positive Factors

Consistent revenue and profit growth

Sustained top-line expansion and rising net margins indicate durable product demand, effective pricing and cost control, and stronger brand acceptance in domestic markets. This enhances reinvestment capacity for distribution, product registrations and marketing across cropping cycles, supporting medium-term growth.

Solid equity base and manageable leverage

A growing equity base and low leverage give the company financial flexibility to fund seasonal working capital, absorb commodity-driven swings, and pursue selective capex or marketing investments without heavy reliance on external financing, strengthening resilience over multiple planting seasons.

Strong operating cash generation

Robust operating cash conversion provides a reliable internal funding source for capex, inventory build-up ahead of sowing seasons, and dividend or debt servicing. Consistent cash generation reduces refinancing risk and supports sustained investment in distribution and product support over coming quarters.

Negative Factors

Fluctuating EBIT margins

Volatile EBIT margins point to inconsistent operational efficiency or exposure to raw-material and pricing cycles common in agrochemicals. That variability can reduce predictability of core earnings, complicate reinvestment planning and weaken ability to sustainably expand margins during adverse input-cost periods.

Rising total liabilities

An increasing liabilities trend, even with current manageable leverage, raises long-term financing and liquidity risk. If liabilities grow faster than equity or cash flows, the company may face higher interest costs or constrained capital for seasonal working capital and strategic initiatives, reducing financial headroom.

Volatile free cash flow with 2023 dip

Intermittent free cash flow volatility, including a notable dip, undermines the reliability of internal funding for capex, inventories and marketing ahead of planting seasons. Such swings can force short-term borrowing or delay investments, increasing execution risk for sustained market share gains.

Insecticides (India) Limited Business Overview & Revenue Model

Company Description

Insecticides (India) Limited manufactures and sells agro chemicals, pesticides, and technical products for agriculture purposes in India and internationally. The company offers insecticides, herbicides, fungicides, and PGRs and bio fertilizers. It also provides household and biological products, and formulations. The company sells its products through a network of approximately 5000 distributors and 60000 retailers under the Tractor brand name. Insecticides (India) Limited was incorporated in 1996 and is based in Delhi, India.

How the Company Makes Money

Insecticides (India) Limited generates revenue primarily through the sale of its agricultural chemical products, including insecticides, herbicides, and fungicides. The company operates a multi-channel distribution strategy that includes direct sales to farmers, partnerships with agricultural cooperatives, and collaborations with distributors and retailers, which helps to expand its market reach. Key revenue streams include domestic sales, where a significant portion comes from the rural farming community, and export sales to international markets. Additionally, INSECTICID invests in research and development to innovate new products, which can lead to higher profit margins. The company may also benefit from strategic partnerships or collaborations with other agribusiness firms to leverage distribution networks and enhance product offerings, contributing to its overall earnings.

Insecticides (India) Limited Financial Statement Overview

Summary

Strong overall fundamentals: consistent revenue growth (2021–2025), improving gross and net margins, solid equity growth, and generally healthy cash generation. Offsetting risks include fluctuating EBIT margins, rising total liabilities, and some free-cash-flow volatility.

Income Statement

Insecticides (India) Limited has shown consistent revenue growth with a substantial increase from 14,021 million in 2021 to 19,999 million in 2025. The gross profit margin has improved significantly, indicating efficient cost management. The net profit margin has also strengthened, reflecting enhanced profitability. However, the EBIT margin has fluctuated, which suggests some operational challenges.

Balance Sheet

The company maintains a solid equity base with an increasing trend in stockholders' equity from 8,203 million in 2021 to 10,846 million in 2025. The debt-to-equity ratio is relatively low and manageable, indicating prudent leverage. The equity ratio shows a stable asset financing structure. Nonetheless, the consistent rise in total liabilities could pose future financial risks.

Cash Flow

Insecticides (India) Limited exhibits a strong free cash flow position with growth over the years, except for a dip in 2023. The operating cash flow to net income ratio indicates robust cash generation relative to reported profits. However, fluctuations in free cash flow highlight potential volatility in capital expenditure and financing activities.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	20.35B	20.00B	19.56B	17.97B	14.98B	14.12B
Gross Profit	6.61B	3.98B	2.82B	3.99B	3.79B	3.35B
EBITDA	2.42B	2.29B	1.72B	1.21B	1.73B	1.48B
Net Income	1.51B	1.42B	1.02B	632.11M	1.07B	939.03M
Balance Sheet
Total Assets	0.00	18.98B	17.13B	16.96B	13.96B	14.26B
Cash, Cash Equivalents and Short-Term Investments	666.26M	666.26M	613.50M	196.42M	360.96M	81.44M
Total Debt	0.00	1.05B	873.09M	1.63B	539.50M	1.00B
Total Liabilities	-10.85B	8.14B	7.00B	7.78B	5.27B	6.06B
Stockholders Equity	10.85B	10.85B	10.14B	9.18B	8.70B	8.20B
Cash Flow
Free Cash Flow	0.00	561.68M	1.35B	-980.91M	675.70M	1.07B
Operating Cash Flow	0.00	934.57M	1.84B	-106.33M	1.35B	1.55B
Investing Cash Flow	0.00	-377.20M	-429.91M	-864.03M	93.09M	-1.13B
Financing Cash Flow	0.00	-610.92M	-980.58M	796.80M	-1.15B	-1.04B

Insecticides (India) Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 710.65
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INSECTICID, the sentiment is Negative. The current price of 710.65 is above the 20-day moving average (MA) of 637.47, above the 50-day MA of 680.56, and below the 200-day MA of 786.62, indicating a bearish trend. The MACD of -21.12 indicates Positive momentum. The RSI at 36.48 is Neutral, neither overbought nor oversold. The STOCH value of 26.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:INSECTICID.

Insecticides (India) Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
INSECTICID	68 Neutral	₹17.66B	11.90	―	0.71%	6.86%	15.64%
ANDHRSUGAR	68 Neutral	₹9.46B	15.05	―	1.06%	16.68%	15.13%
DALMIASUG	68 Neutral	₹22.40B	6.84	―	2.00%	17.71%	18.17%
RANASUG	66 Neutral	₹1.67B	4.51	―	―	8.83%	160.77%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
BAJAJHIND	49 Neutral	₹20.53B	-12.24	―	―	-11.72%	-439.12%
DHARSUGAR	46 Neutral	₹286.52M	―	―	―	―	―

Insecticides (India) Limited Corporate Events

Insecticides (India) Clears Q3 FY26 Results, Declares Interim Dividend

Insecticides (India) Limited’s board has approved the unaudited standalone and consolidated financial results for the third quarter and nine months ended 31 December 2025, following review and recommendation by the audit committee and a limited review by the company’s joint statutory auditors. Alongside the results, the board has declared an interim dividend of Rs 2 per equity share (20% of the face value of Rs 10) for the 2025-26 financial year, with a record date of 6 February 2026 and payment to be made on or after 11 February 2026, signaling continued capital returns to shareholders and reflecting the board’s confidence in the company’s financial performance over the period.

Insecticides (India) Reports No Re‑lodgement Requests for Physical Share Transfers

Insecticides (India) Limited has notified the stock exchanges that, in line with a SEBI circular governing the special window for re-lodgement of transfer requests for physical shares, it has received a status report from its Registrar and Share Transfer Agent, Alankit Assignments Limited, as of December 31, 2025. The report confirms that during the relevant period there were no shareholder requests for re-lodgement of transfers of physical share certificates, resulting in no approvals or rejections and no processing time recorded, indicating that the company’s share transfer activity has effectively transitioned away from physical share transfer requests under the current regulatory framework.

Insecticides (India) Limited Releases Q2 & H1 FY 2025-26 Earnings Presentation

Insecticides (India) Limited has released its earnings presentation for the second quarter and half-year of the fiscal year 2025-26, ending on September 30, 2025. This release is significant for stakeholders as it provides insights into the company’s financial performance and strategic positioning within the agrochemical industry, potentially impacting investor decisions and market perception.